KIF25
geneOn this page
Summary
KIF25 (kinesin family member 25, HGNC:6390) is a protein-coding gene on chromosome 6q27, encoding Kinesin-like protein KIF25 (Q9UIL4). Minus-end microtubule-dependent motor protein.
The protein encoded by this gene is a member of the kinesin-like protein family. Protein family members are microtubule-dependent molecular motors that transport organelles within cells and move chromosomes during cell division. However, the particular function of this gene product has not yet been determined. Two alternatively spliced transcript variants which encode products have been described. Other splice variants have been found that lack exon 2 and the initiation codon for translation.
Source: NCBI Gene 3834 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 84 total
- MANE Select transcript:
NM_030615
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:6390 |
| Approved symbol | KIF25 |
| Name | kinesin family member 25 |
| Location | 6q27 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000125337 |
| Ensembl biotype | protein_coding |
| OMIM | 603815 |
| Entrez | 3834 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 4 protein_coding, 4 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000443060, ENST00000496008, ENST00000504593, ENST00000515361, ENST00000643607, ENST00000644536, ENST00000645382, ENST00000652547, ENST00000955753
RefSeq mRNA: 2 — MANE Select: NM_030615
NM_005355, NM_030615
CCDS: CCDS5305
Canonical transcript exons
ENST00000643607 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001150227 | 168042561 | 168042716 |
| ENSE00001150232 | 168041969 | 168042151 |
| ENSE00001150241 | 168040065 | 168040216 |
| ENSE00001150248 | 168038553 | 168038729 |
| ENSE00001150259 | 168030773 | 168030847 |
| ENSE00001164042 | 168029492 | 168029677 |
| ENSE00002029735 | 168003614 | 168003703 |
| ENSE00002061661 | 168017973 | 168018040 |
| ENSE00002068602 | 167999092 | 167999320 |
| ENSE00002083639 | 168002543 | 168002659 |
| ENSE00003499889 | 168033882 | 168034031 |
| ENSE00003815819 | 167997671 | 167998870 |
| ENSE00003820921 | 168044827 | 168045091 |
Expression profiles
Bgee: expression breadth ubiquitous, 151 present calls, max score 87.05.
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.05 | gold quality |
| buccal mucosa cell | CL:0002336 | 77.45 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.91 | silver quality |
| myocardium | UBERON:0002349 | 73.68 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 72.01 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 71.36 | gold quality |
| cerebellar cortex | UBERON:0002129 | 71.26 | gold quality |
| apex of heart | UBERON:0002098 | 70.70 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 70.70 | gold quality |
| cerebellum | UBERON:0002037 | 70.48 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 70.22 | gold quality |
| omental fat pad | UBERON:0010414 | 70.03 | gold quality |
| peritoneum | UBERON:0002358 | 70.01 | gold quality |
| right frontal lobe | UBERON:0002810 | 69.01 | gold quality |
| spinal cord | UBERON:0002240 | 68.08 | gold quality |
| putamen | UBERON:0001874 | 67.54 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 67.11 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 67.03 | gold quality |
| parotid gland | UBERON:0001831 | 66.94 | gold quality |
| adipose tissue | UBERON:0001013 | 66.44 | gold quality |
| caudate nucleus | UBERON:0001873 | 66.10 | gold quality |
| substantia nigra | UBERON:0002038 | 65.05 | gold quality |
| nucleus accumbens | UBERON:0001882 | 65.02 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 65.01 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 64.67 | gold quality |
| prefrontal cortex | UBERON:0000451 | 64.65 | gold quality |
| amygdala | UBERON:0001876 | 64.63 | gold quality |
| periodontal ligament | UBERON:0008266 | 64.39 | gold quality |
| hypothalamus | UBERON:0001898 | 64.32 | gold quality |
| frontal cortex | UBERON:0001870 | 63.95 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.78 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- The activity of Kif25 during interphase is required to maintain a centred nucleus to ensure the spindle is stably oriented at the onset of mitosis. (PMID:28263957)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | kif25 | ENSDARG00000017532 |
Paralogs (41): KIF1B (ENSG00000054523), KIF26A (ENSG00000066735), KIF2A (ENSG00000068796), KIF22 (ENSG00000079616), KIF3C (ENSG00000084731), KIF9 (ENSG00000088727), KIF16B (ENSG00000089177), KIF4A (ENSG00000090889), KIF3B (ENSG00000101350), KIF20A (ENSG00000112984), KIF21B (ENSG00000116852), KIF17 (ENSG00000117245), KIF14 (ENSG00000118193), KIF18A (ENSG00000121621), KIF1C (ENSG00000129250), KIF1A (ENSG00000130294), KIF3A (ENSG00000131437), KIF12 (ENSG00000136883), KIF13A (ENSG00000137177), KIF23 (ENSG00000137807), KIF11 (ENSG00000138160), CENPE (ENSG00000138778), KIF21A (ENSG00000139116), KIFC3 (ENSG00000140859), KIF2B (ENSG00000141200), KIF2C (ENSG00000142945), KIF5A (ENSG00000155980), KIF26B (ENSG00000162849), KIF15 (ENSG00000163808), KIF6 (ENSG00000164627), KIF27 (ENSG00000165115), KIF7 (ENSG00000166813), KIFC2 (ENSG00000167702), KIF5C (ENSG00000168280), KIF5B (ENSG00000170759), KIF18B (ENSG00000186185), KIF24 (ENSG00000186638), KIF19 (ENSG00000196169), KIF13B (ENSG00000197892), KIF4B (ENSG00000226650)
Protein
Protein identifiers
Kinesin-like protein KIF25 — Q9UIL4 (reviewed: Q9UIL4)
Alternative names: Kinesin-like protein 3
All UniProt accessions (2): Q9UIL4, A0A494C0P5
UniProt curated annotations — full annotation on UniProt →
Function. Minus-end microtubule-dependent motor protein. Acts as a negative regulator of centrosome separation required to prevent premature centrosome separation during interphase. Required to maintain a centered nucleus to ensure that the spindle is stably oriented at the onset of mitosis. May also act as a negative regulator of amino acid starvation-induced autophagy.
Subunit / interactions. Homotetramer.
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome.
Similarity. Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Kinesin family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9UIL4-1 | 1 | yes |
| Q9UIL4-2 | 2 |
RefSeq proteins (2): NP_005346, NP_085118* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001752 | Kinesin_motor_dom | Domain |
| IPR019821 | Kinesin_motor_CS | Conserved_site |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR027640 | Kinesin-like_fam | Family |
| IPR036961 | Kinesin_motor_dom_sf | Homologous_superfamily |
Pfam: PF00225
UniProt features (12 total): sequence variant 4, region of interest 3, chain 1, domain 1, sequence conflict 1, binding site 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UIL4-F1 | 71.90 | 0.30 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (1): 65–72
Function
Pathways and Gene Ontology
Reactome pathways
8 pathways
| ID | Pathway |
|---|---|
| R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic |
| R-HSA-983189 | Kinesins |
| R-HSA-109582 | Hemostasis |
| R-HSA-199991 | Membrane Trafficking |
| R-HSA-5653656 | Vesicle-mediated transport |
| R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic |
| R-HSA-8856688 | Golgi-to-ER retrograde transport |
| R-HSA-983231 | Factors involved in megakaryocyte development and platelet production |
MSigDB gene sets: 101 (showing top):
GOBP_CHROMOSOME_ORGANIZATION, GOBP_ESTABLISHMENT_OF_SPINDLE_ORIENTATION, GOBP_REGULATION_OF_AUTOPHAGY, GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY, GOBP_PROTEIN_HOMOTETRAMERIZATION, GOBP_SPINDLE_LOCALIZATION, GOCC_KINESIN_COMPLEX, REACTOME_MEMBRANE_TRAFFICKING, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGY, GOBP_ESTABLISHMENT_OF_CELL_POLARITY, GOBP_ORGANELLE_FISSION, GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS, GOBP_REGULATION_OF_CATABOLIC_PROCESS, GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE
GO Biological Process (8): mitotic sister chromatid segregation (GO:0000070), organelle organization (GO:0006996), microtubule-based movement (GO:0007018), negative regulation of autophagy (GO:0010507), negative regulation of mitotic centrosome separation (GO:0046603), protein homotetramerization (GO:0051289), establishment of spindle orientation (GO:0051294), nucleus localization (GO:0051647)
GO Molecular Function (7): microtubule motor activity (GO:0003777), ATP binding (GO:0005524), microtubule binding (GO:0008017), minus-end-directed microtubule motor activity (GO:0008569), ATP hydrolysis activity (GO:0016887), nucleotide binding (GO:0000166), cytoskeletal motor activity (GO:0003774)
GO Cellular Component (5): cytoplasm (GO:0005737), centrosome (GO:0005813), kinesin complex (GO:0005871), microtubule (GO:0005874), cytoskeleton (GO:0005856)
Reactome top-level categories
Rollup of top-6 pathways:
| Category | Pathways |
|---|---|
| Golgi-to-ER retrograde transport | 1 |
| Factors involved in megakaryocyte development and platelet production | 1 |
| Vesicle-mediated transport | 1 |
| Membrane Trafficking | 1 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | 1 |
| Hemostasis | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| ATP-dependent activity | 2 |
| sister chromatid segregation | 1 |
| mitotic nuclear division | 1 |
| mitotic cell cycle process | 1 |
| cellular component organization | 1 |
| microtubule-based process | 1 |
| autophagy | 1 |
| negative regulation of catabolic process | 1 |
| regulation of autophagy | 1 |
| mitotic centrosome separation | 1 |
| negative regulation of cell cycle process | 1 |
| regulation of mitotic centrosome separation | 1 |
| protein homooligomerization | 1 |
| protein tetramerization | 1 |
| establishment of cell polarity | 1 |
| establishment of spindle localization | 1 |
| organelle localization | 1 |
| cytoskeletal motor activity | 1 |
| polypeptide conformation or assembly isomerase activity | 1 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| tubulin binding | 1 |
| microtubule motor activity | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| molecular_function | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| centriole | 1 |
| microtubule organizing center | 1 |
| microtubule associated complex | 1 |
| microtubule cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
1699 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KIF25 | FRMD1 | Q8N878 | 627 |
| KIF25 | DYNLT2 | Q8IZS6 | 558 |
| KIF25 | DACT2 | Q5SW24 | 557 |
| KIF25 | CEP170 | Q5SW79 | 500 |
| KIF25 | ADAMTS18 | Q8TE60 | 491 |
| KIF25 | PHF10 | Q8WUB8 | 484 |
| KIF25 | WDR62 | O43379 | 462 |
| KIF25 | SMOC2 | Q9H3U7 | 459 |
| KIF25 | WDR27 | A2RRH5 | 457 |
| KIF25 | CHRM5 | P08912 | 437 |
| KIF25 | KRTAP19-7 | Q3SYF9 | 433 |
| KIF25 | SFT2D1 | Q8WV19 | 418 |
| KIF25 | PRG4 | Q92954 | 411 |
| KIF25 | C1orf232 | A0A0U1RR37 | 411 |
| KIF25 | LRG1 | P02750 | 400 |
| KIF25 | A0A1W2PQ80 | A0A1W2PQ80 | 400 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KIF25 | DDX19B | psi-mi:“MI:0915”(physical association) | 0.400 |
| MYC | PDZD2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (1): DDX19B (Affinity Capture-MS)
ESM2 similar proteins: A8WFU8, B7ZC32, B7ZNG0, D3YXS5, F4JGP4, F8WLE0, O35071, O35231, O35787, O43896, O95235, P18105, P38935, P40694, P46864, P46875, P79955, P97329, Q00653, Q07970, Q0J9V3, Q14147, Q15027, Q1HG60, Q29RT6, Q2M1P5, Q2R2P7, Q4R918, Q58G59, Q5I0E8, Q5XI63, Q5ZLK6, Q60443, Q60560, Q6P3R1, Q7ZYL5, Q80SX8, Q80TF6, Q8K2H4, Q96FN5
Diamond homologs: B7ZNG0, E9Q5G3, O16844, O95239, P27895, Q02241, Q292S8, Q2M1P5, Q4R918, Q6FXI5, Q91784, Q9UIL4, F4IIS5, F4JX00, O23826, Q58G59, A2ZRG4, A3BFT0, A8BB91, B2GU58, B3H6Z8, B7EJ91, B9EUM5, B9F7C8, B9FAF3, B9FL70, B9FTR1, B9G2X9, B9G8P1, F4HZF0, F4I1T9, F4IAR2, F4IBQ9, F4IJK6, F4IL57, F4J2M6, F4JGP4, F4K0J3, F4K4C5, G5EGS3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
84 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 69 |
| Likely benign | 6 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1997 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:168017967:TCTCA:T | acceptor_loss | 1.0000 |
| 6:168017968:CTCA:C | acceptor_loss | 1.0000 |
| 6:168017969:TCAGG:T | acceptor_loss | 1.0000 |
| 6:168017970:CAGGA:C | acceptor_loss | 1.0000 |
| 6:168017971:A:AG | acceptor_gain | 1.0000 |
| 6:168017971:AG:A | acceptor_gain | 1.0000 |
| 6:168017972:G:GG | acceptor_gain | 1.0000 |
| 6:168017972:GG:G | acceptor_gain | 1.0000 |
| 6:168017972:GGAA:G | acceptor_gain | 1.0000 |
| 6:168018036:GAAAG:G | donor_gain | 1.0000 |
| 6:168018038:AAGGT:A | donor_loss | 1.0000 |
| 6:168018039:AGGTA:A | donor_loss | 1.0000 |
| 6:168018040:GGTA:G | donor_loss | 1.0000 |
| 6:168018041:G:GG | donor_gain | 1.0000 |
| 6:168018042:T:G | donor_loss | 1.0000 |
| 6:168038548:CGCA:C | acceptor_loss | 1.0000 |
| 6:168038549:GCAG:G | acceptor_loss | 1.0000 |
| 6:168038550:CAGGC:C | acceptor_loss | 1.0000 |
| 6:168038551:A:AG | acceptor_gain | 1.0000 |
| 6:168038551:AG:A | acceptor_gain | 1.0000 |
| 6:168038552:G:GT | acceptor_gain | 1.0000 |
| 6:168038552:GG:G | acceptor_gain | 1.0000 |
| 6:168038552:GGC:G | acceptor_gain | 1.0000 |
| 6:168038552:GGCT:G | acceptor_gain | 1.0000 |
| 6:168038552:GGCTC:G | acceptor_gain | 1.0000 |
| 6:168038728:GA:G | donor_gain | 1.0000 |
| 6:168038729:AGT:A | donor_loss | 1.0000 |
| 6:168038730:G:GG | donor_gain | 1.0000 |
| 6:168038730:GTG:G | donor_loss | 1.0000 |
| 6:168038731:TGA:T | donor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000026375 (6:168040419 A>G), RS1000075927 (6:168045228 G>A,C,T), RS1000160743 (6:168035252 C>G,T), RS1000210407 (6:167997966 T>C), RS1000233341 (6:168030192 G>A), RS1000303294 (6:167996199 C>A,G), RS1000359225 (6:168035706 T>C), RS1000517887 (6:168041292 C>A,G,T), RS1000530541 (6:168036819 T>G), RS1000603281 (6:167997718 A>G), RS1000743495 (6:168029326 A>G), RS1000778430 (6:168014607 CA>C), RS1000897415 (6:168020168 C>T), RS1000905711 (6:168020418 G>A), RS1000949782 (6:167998968 C>T)
Disease associations
OMIM: gene MIM:603815 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001820_2 | Metabolite levels (5-HIAA) | 6.000000e-06 |
| GCST006979_720 | Heel bone mineral density | 1.000000e-34 |
| GCST012146_1 | Hemoglobin levels | 5.000000e-06 |
| GCST012146_15 | Hemoglobin levels | 5.000000e-07 |
| GCST90014243_2 | Kawasaki disease | 4.000000e-08 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005132 | 5-HIAA measurement |
| EFO:0009270 | heel bone mineral density |
| EFO:0004509 | hemoglobin measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation | 2 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| mono-(2-ethylhexyl)phthalate | increases abundance, increases methylation | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | decreases expression, affects response to substance, increases expression, affects cotreatment | 1 |
| bisphenol S | increases methylation, affects cotreatment | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Arsenic | increases methylation | 1 |
| Diethylhexyl Phthalate | increases abundance, increases methylation | 1 |
| Lipopolysaccharides | decreases expression, affects response to substance, increases expression, affects cotreatment | 1 |
| Methapyrilene | increases methylation | 1 |
| Phthalic Acids | decreases methylation | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Kawasaki disease